SOPHiA GENETICS SA Research and Development Expenses 2020-2024 | SOPH

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

SOPHiA GENETICS SA research and development expenses from 2020 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

SOPHiA GENETICS SA Research and Development Expenses 2020-2024 | SOPH

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

SOPHiA GENETICS SA research and development expenses from 2020 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Related Stocks
Company Name	Market Cap
Tempus AI (TEM)	$8.5B
Inspire Medical Systems (INSP)	$5.3B
Hims & Hers Health (HIMS)	$5.1B
Privia Health (PRVA)	$2.5B
Enovis (ENOV)	$2.5B
IRhythm Technologies (IRTC)	$2.4B
Azenta (AZTA)	$2B
Omnicell (OMCL)	$2B
Clover Health Investments (CLOV)	$1.6B
10x Genomics (TXG)	$1.6B
Schrodinger (SDGR)	$1.4B
Phreesia (PHR)	$1.1B
Butterfly Network (BFLY)	$650M
Standard BioTools (LAB)	$562M
Talkspace (TALK)	$522M
Fulgent Genetics (FLGT)	$520M
Definitive Healthcare (DH)	$483M
Health Catalyst (HCAT)	$459M
TruBridge (TBRG)	$244M
Pulmonx (LUNG)	$237M
American Well (AMWL)	$122M
EUDA Health Holdings (EUDA)	$107M
P3 Health Partners (PIII)	$75M
HeartBeam (BEAT)	$67M
111 (YI)	$53M
CareCloud (CCLD)	$46M
Zepp Health (ZEPP)	$40M
SHL Telemedicine (SHLT)	$40M
Outset Medical (OM)	$39M
Movano (MOVE)	$20M